Is Your Portfolio Missing Loblaw Stock?

Loblaw (TSX:L) isn’t just the largest grocer in Canada. Loblaw stock holds massive long-term potential wrapped in a defensive shell.

| More on:

Some of the best long-term options for investors to consider are stocks that we interact with on a daily basis yet often dismiss as investments. These everyday stocks provide a necessary service that we take for granted, making them great options. One such option is Loblaw (TSX:L). Here’s why you need some Loblaw stock in your portfolio.

Loblaw stock: The grocer that does so much more

Loblaw is best known as Canada’s largest grocer and food stock, but the company is an absolute behemoth. The company also happens to be one of Canada’s largest employers with approximately 190,000 employees in over 2,400 locations across Canada.

Loblaw’s food segment includes over a dozen well-known brands and banners. Turning to health and wellness, Loblaw’s operates the most extensive pharmacy network in Canada through its Shoppers Drug Mart brand. That pharmacy network also allows Loblaw the capacity to cross-sell some of its grocery merchandise in its pharmacy stores.

The company also boasts a growing presence in fashion, through its Joe Fresh brand. The brand comprises both freestanding stores as well as retail locations within Loblaw and Shoppers stores. If that’s not enough, Loblaw also boasts a financial arm as well as its PC Optimum rewards program.

In short, Loblaw has its tentacles in multiple aspects of Canadian’s lives, making Loblaw stock a very defensive, and potentially lucrative long-term option for investors.

Let’s talk results

One of the other benefits of operating a large business that blankets the entire Canadian market across multiple verticals is diversification. And that was evident in the most recent quarter.

In Loblaw’s most recent quarterly update announced last month, the company announced revenue of $12,995 million. This is reflected in a 6%, or $733 million increase over the prior year. Loblaw’s retrial arm saw strong sales of $12,795 million, reflecting a 5.7%, or $690 million increase.

With that retail segment, both food and drug same-store sales saw increases in the quarter of 3.1% and 7.4%, respectively. E-commerce sales dipped 1.1% year over year, reflecting the higher level of online sales in the prior year when some lockdowns were still in place.

The financial services segment also saw strong growth, fueled by higher interest from credit card receivables. Specifically, revenue from the segment surged $52 million, or 19% over the prior period, coming in at $326 million for the quarter.

Overall, the company earned $1.55 per common share on an adjusted basis. This reflects a $0.19 per common share or 14% increase over the prior period.

What about dividends?

When it comes to dividends, Loblaw stock is often overlooked as a viable income producer. That’s unfortunate, because the stock does have plenty to offer income investors.

Loblaw currently pays out a quarterly dividend that carries a respectable yield of 1.53%. While that’s not the highest return on the market, it is well covered and rising.

By way of example, given a $40,000 investment in Loblaw stock (as part of a larger, well-diversified portfolio), investors can expect a first-year income of just over $600. The reason I say “first year” is because Loblaw continues to provide annual bumps to that dividend.

In fact, in the most recent quarterly announcement, Loblaw announced a 10% bump to its dividend, bringing the per common share payout to $0.446. That represents the 12th consecutive annual increase to the dividend. That fact alone makes Loblaw stock an intriguing option for buy-and-forget investors to consider.

That’s not to say that Loblaw stock isn’t a great long-term growth option. Over the trailing two years, the stock has surged over 50%; over the past five years, that surges to an incredible 118% gain.

Final thoughts

No stock, even a defensive option like Loblaw, is without risk. Fortunately, Loblaw is a well-diversified market leader within its segments, with plenty of long-term growth potential.

In my opinion, Loblaw is a great long-term option for investors to consider as part of a larger, well-diversified portfolio.

Fool contributor Demetris Afxentiou has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

A solar cell panel generates power in a country mountain landscape.
Energy Stocks

Here’s How Many Shares of Capital Power You Should Own to Get $1,000 in Dividends

Discover the potential of Capital Power as a leading dividend stock on the TSX for reliable returns and future growth.

Read more »

dividends grow over time
Investing

2 Growth Stocks I Expect to Surge Well Into This Year and Beyond

These TSX stocks will likely deliver solid returns as they are benefiting from strong demand for their products, technology, and…

Read more »

Happy golf player walks the course
Dividend Stocks

How a TFSA Can Generate $4,360 in Annual Tax-Free Passive Income

This strategy can boost yield while reducing portfolio risk.

Read more »

Pile of Canadian dollar bills in various denominations
Dividend Stocks

Build a Passive-Income Portfolio With Just $25,000

Turn $25,000 into monthly passive income! Discover how a single TSX ETF, a TFSA, and a DRIP can build a…

Read more »

athlete ties shoes before starting to exercise
Dividend Stocks

Chasing Passive Income? These 2 Canadian Dividend Stocks Yield 9% and Can Back It Up

High yields look scary until you separate “cash flow coverage” from “headline yield,” and these two TSX names show both…

Read more »

a sign flashes global stock data
Dividend Stocks

My 3 Favourite TSX Stocks to Buy Right This Moment

Protect your investment capital by adding these three TSX stocks to your self-directed investment portfolio.

Read more »

A glass jar resting on its side with Canadian banknotes and change inside.
Dividend Stocks

How to Use Your TFSA to Double Your Annual Contribution

Down more than 25% from all-time highs, this TSX dividend stock is a top buy for your TFSA in 2026.

Read more »

Nurse uses stethoscope to listen to a girl's heartbeat
Dividend Stocks

How to Structure a $50,000 TFSA for Practically Constant Income

Given their solid fundamentals, stronger balance sheets, and healthy growth prospects, these two REITs would be excellent additions to your…

Read more »